Partner David Rosen was quoted in an article published in Business Insider on April 18, 2014, titled “Why America Needs This Dangerous New Painkiller.” The article discusses Zohydro, a new hydrocodone painkiller, and the sharp criticism it has drawn because of the potential for abuse since it does not yet have tamper-resistant technology that would make it more difficult to crush and snort. Rosen was quoted saying, “”With respect to having a product available for use for chronic pain, when the drug is used appropriately, yes, this is a good call.”
People
Related News
20 December 2024
In the News
Foley Attorneys Explore Alice Patent Eligibility Analysis Divergence
Foley & Lardner LLP attorneys Jack Carroll, Chethan Srinivasa, and Kevin Malaney authored the IP Litigator article, "Alice Patent Eligibility Analysis Divergence Before USPTO and District Court."
19 December 2024
In the News
Jason Mehta Shares Perspective on Biggest Government Contracts Cases of 2024
Foley & Lardner LLP partner Jason Mehta commented on the legal battle over the constitutionality of the False Claims Act's qui tam provision in the Law360 article, "Top Gov't Contracts Cases Of 2024."
19 December 2024
In the News
Key Rulings On Sentencing Guidelines After Loper Bright
The U.S. Sentencing Guidelines are instrumental in criminal sentencing, as they provide courts with advisory ranges for imposing sentences.